$8.65
0.465.62%
Last update: Nov 6, 5:02 PM
Bicara Therapeutics Inc
BCAXNASDAQ
Bicara Therapeutics (BCAX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.81 | $-0.65 | $-0.68 | $-0.54 |
| Actual | $-0.82 | $-0.93 | $-0.68 | $-0.67 |
| Surprise | -1.23% | -43.1% | 0.00% | -24.1% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | — | $0 | — |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.86 | $-0.89 | $-0.90 | $-0.93 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $-0.82 | $-0.81 | -1.23 % |
| Q1 | May 11, 2026 | $-0.93 | $-0.65 | -43.1 % |
| Q4 | Mar 30, 2026 | $-0.68 | $-0.68 | 0.00 % |
| Q3 | Nov 10, 2025 | $-0.67 | $-0.54 | -24.1 % |
